Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re NAV, Dividend and Offer

27 Jan 2014 17:00

RNS Number : 6223Y
Maven Income and Growth VCT 5 PLC
27 January 2014
 



Maven Income and Growth VCT 5 PLC

 

Net Asset Value, Proposed Final Dividend and Offer for Subscription

 

The Directors of Maven Income and Growth VCT 5 PLC confirm that the unaudited net asset value of the Company as at 30 November 2013 was 37.09p per Ordinary Share.

 

The Directors are recommending the payment of a final dividend of 1.35p per Ordinary Share in respect of the year ended 30 November 2013, to be paid on 30 May 2014 to Shareholders on the register at close of business on 9 May 2014. Subject to the approval of Shareholders at the Annual General Meeting, the proposed final dividend will result in an aggregate payment of 2.00p per share in respect of the year ended 30 November 2013, which represents an increase of 21.21% over the total payment for the prior year.

 

Furthermore, the Directors confirm an unaudited net asset value of the Company as at 21 January 2014 of 40.63p per Ordinary Share, representing an increase of 9.54% over the net asset value as at 30 November 2013 and an increase of 11.71% over the previously announced net asset value of 36.37p at 10 October 2013, which was used as the basis for the Offer Price set out in the Prospectus for the Offer for Subscription issued by the Company on 24 October 2013. The rise in the net asset value over that period reflects the performance of AIM quoted securities in general and, in particular, certain investments in the Company's portfolio within the energy sector. As the Board recognises that the share prices of its AIM quoted investments in general, and these investments in particular, may remain volatile, the Directors intend to review the net asset value of the Company prior to the first allotment of shares under the Offer for Subscription, due to take place on or after 3 February 2014, and reserve their discretion to amend the Offer Price in accordance with the Prospectus. Any variation in the Offer Price will be announced through a regulatory information service.

 

In accordance with Listing Rule 15.5.1, and further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Section 118C of the Financial Services and Markets Act 2000) that the Directors and the Company may have in their possession relating to the Company during the period leading up to the announcement of its financial results for the year ended 30 November 2013 has previously been notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

27 January 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEAFMWFLSEIF
Date   Source Headline
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
21st Mar 20254:35 pmRNSNet Asset Value(s)
12th Mar 20254:54 pmRNSAnnual Financial Report
26th Feb 20254:41 pmRNSTransaction in Own Shares
26th Feb 202510:33 amRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:12 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
17th Dec 20243:27 pmRNSDirectorate Change
13th Dec 20242:45 pmRNSUnaudited Net Asset Value
14th Nov 20242:58 pmRNSResult of General Meeting
8th Oct 20245:01 pmRNSTransaction in Own Shares
4th Oct 20244:18 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 20249:47 amRNSIssue of Equity
5th Sep 20242:28 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:36 pmRNSUnaudited Net Asset Value
12th Jul 20244:37 pmRNSTransaction in Own Shares
12th Jul 20244:09 pmRNSHalf-year Report
10th Jul 20245:05 pmRNSTransaction in Own Shares
5th Jul 202412:38 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
9th May 20244:05 pmRNSTransaction in Own Shares
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.